Showing results (381-390 of 422) with videos related to

Sort By:
Pageof 43
Physical Review Letters|February 9, 2019
Stellarators Resist Turbulent Transport on the Electron Larmor ScaleG G Plunk, P Xanthopoulos, G M Weir, et al.
Metabolism: Clinical and Experimental|November 26, 2019
Irradiation impairs mitochondrial function and skeletal muscle oxidative capacity: significance for metabolic complications in cancer survivorsNadia M L Amorim, Anthony Kee, Adelle C F Coster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast RadiotherapyFei-Fei Liu, Wei Shi, Susan J Done, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2006
Transferable anticancer innate immunity in spontaneous regression/complete resistance miceAmy M Hicks, Gregory Riedlinger, Mark C Willingham, et al.
Diabetologia|July 27, 2012
Skeletal muscle-specific overproduction of constitutively activated c-Jun N-terminal kinase (JNK) induces insulin resistance in miceD C Henstridge, C R Bruce, C P Pang, et al.
Autism in Adulthood : Challenges and Management|November 3, 2025
"A combination of everything": a mixed-methods approach to the factors which autistic people consider important in suicidalityR L Moseley, S J Marsden, C L Allison, et al.
Indian Journal of Microbiology|October 27, 2012
The enzymatic basis for pesticide bioremediationColin Scott, Gunjan Pandey, Carol J Hartley, et al.
Lipids|March 16, 2013
Variability in associations of phosphatidylcholine molecular species with metabolic syndrome in Mexican-American familiesHemant Kulkarni, Peter J Meikle, Manju Mamtani, et al.
Hypertension (Dallas, Tex. : 1979)|June 27, 2013
Plasma lipidomic profile signature of hypertension in Mexican American families: specific role of diacylglycerolsHemant Kulkarni, Peter J Meikle, Manju Mamtani, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2008
Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding modeM Raymond V Finlay, David G Acton, David M Andrews, et al.
Pageof 43